A more benign environment than we were expecting means we're revising our 2023-2024 EUR/USD profile substantially higher.Read full newsRead More
ACADIA Pharmaceuticals had one major disappointment in 2022 but has some potential new drug approvals on the horizon. Click here to read my analysis of ACAD.Read full newsRead More
The period after World War II could be a good comparison for the current inflationary period. Click for our view of where markets may head in 2023.Read full newsRead More
QuantaSing Group has filed proposed terms for a $41 million U.S. IPO. It provides online learning services for adults in China. Click here for more on QSG.Read full newsRead More
Vizsla Silver Corp. is a silver development company with great risk but also tremendous upside potential. Click here to read our view of VZLA stock.Read full newsRead More
Pacer Global Cash Cows Dividend ETF holds 100 large cap dividend stocks in developed countries. It is well-balanced. Click here for more on GCOW.Read full newsRead More
United Microelectronics Corporation (NYSE:NYSE:UMC) Q4 2022 Results Conference Call January 16, 2023 4:00 AM ETCompany ParticipantsMichael Lin - Head, IRJason Wang - PresidentChi-Tung Liu -...Read full newsRead More
I see negative sentiment on Elon Musk's actions as a misplaced driver for the sharp decline of Tesla's share prices in the past few months. See my view of TSLA.Read full newsRead More
Medical Properties Trust, Inc.'s future is unfolding as management guided. Pipeline to pay all past due amounts, though some will be deferred. Read more here.Read full newsRead More
Booz Allen Hamilton trades at a premium PEG in a market that has seen a general P/E compression in 2022. Find out why we rate BAH stock a Sell.Read full newsRead More
Moelis has the most to gain as certainty returns to the market. Click here for a full investment analysis of MC stock.Read full newsRead More
Fanuc's valuations are already pretty depressed based on a historical comparison. A Hold rating for FANUY stock is appropriate in my opinion.Read full newsRead More
Moderna recently delivered surprisingly positive results on its personalized cancer vaccine study with Merck's Keytruda. Click here for more on MRNA.Read full newsRead More
Keyence Corporation is expected to witness faster top line growth going forward, and this is achievable. Click here for my long-term view of KYCCF stock.Read full newsRead More
Denali Therapeutics Inc. has major partnerships and an active set of programs. They are flush with cash. Click for more on DNLI.Read full newsRead More
Alamos Gold indicated revenue of $232 million for 4Q22, a new record and total revenues for 2022 were $821 million. Read more to see my recommendation on AGI stock.Read full newsRead More
BLOK, Amplify Transformational Data Sharing ETF, is a broadly diversified crypto equities exchange-traded fund. Read why I'm upgrading BLOK from sell to neutral.Read full newsRead More
Google and Meta are about to take their competition to the next level. Find out if YouTube Shorts and Meta's Reels would be able to gain a greater market share.Read full newsRead More
SoFi Technologies' Q4 revenue should come in around $426.5 million. SOFI is still grossly overvalued compared to peers and can fall further. Click here for more.Read full newsRead More
Falling wages reduce the odds of a 1970s style outcome. The biggest lesson for me was the sheer uncertainty of the future. Click here to read.Read full newsRead More